Bank of America
SLRN

Bank of America’s ACELYRIN SLRN Stock Holding History

Bank of America’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,410
Closed -$89.9K – 8643
2025
Q1 		$89.9K Sell
36,410
-161,425
-82% -$384K ﹤0.01% 6531
2024
Q4 		$621K Buy
197,835
+19,165
+11% +$92.8K ﹤0.01% 5382
2024
Q3 		$881K Buy
178,670
+123,536
+224% +$638K ﹤0.01% 5133
2024
Q2 		$243K Sell
55,134
-38,439
-41% -$180K ﹤0.01% 5785
2024
Q1 		$632K Buy
93,573
+10,293
+12% +$78.2K ﹤0.01% 5204
2023
Q4 		$621K Sell
83,280
-141,989
-63% -$1.21M ﹤0.01% 5340
2023
Q3 		$2.29M Buy
225,269
+223,428
+12,136% +$4.75M ﹤0.01% 4117
2023
Q2 		$38.5K Buy
+1,841
New +$37.7K ﹤0.01% 6542

Other funds holding SLRN

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of America's SLRN Position: Q2 2025 in Review

Bank of America sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 36,410 shares — an estimated $89.9K sold.

Bank of America first reported a position in SLRN in Q2 2023 and held it in 8 quarters. The position peaked at $2.29M in Q3 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Bank of America reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Bank of America sold 36,410 ACELYRIN shares in Q2 2025, an estimated $89.9K.
  • Bank of America first reported a position in ACELYRIN in Q2 2023 and held it in 8 quarters.
  • Bank of America's ACELYRIN position peaked at $2.29M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.